The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine
Clinical Pharmacology & Therapeutics · 2026-02 · 119 (2) · 318-321
DOI: 10.1002/cpt.70180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 21.12.2025. Verfasst von Charles Khouri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Evidence-Based Medicine, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
In recent years, different national and international regulatory authorities, notably the FDA, have made their adverse event repositories publicly available, offering user‐friendly dashboards. This has led to a large increase in low‐quality, poorly reported research using adverse event reporting databases (e.g., FDA’s Adverse Event Reporting System [FAERS]). Such publications producing thousands of statistical associations erroneously presented as “safety signals” can create unscientifically grounded alarm with considerable impact on healthcare provider practices and patient behaviors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Univ. Grenoble Alpes, Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.
- Univ. Grenoble Alpes, Inserm U1300, HP2, Grenoble, France.
- Uppsala Monitoring Centre, Uppsala, Sweden.
- Springer Nature, Auckland, New Zealand.
- INSERM, BPH, Team AHeaD U1219, Université de Bordeaux, Bordeaux, France.
- INSERM U1219, CHU de Bordeaux, Service de Pharmacologie Médicale, Bordeaux, France.
ORCID-Profile: Charles Khouri, Alex Hlavaty, Michele Fusaroli, Nitin Joshi, Francesco Salvo, Andrew Bate, Antoine Pariente, Emanuel Raschi
Zitieren
APA
Khouri, C., Hlavaty, A., Fusaroli, M., Joshi, N., Salvo, F., Bate, A., Pariente, A., & Raschi, E. (2026). The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine. Clinical Pharmacology & Therapeutics, 119(2), 318-321. https://doi.org/10.1002/cpt.70180
Vancouver
Khouri C, Hlavaty A, Fusaroli M, Joshi N, Salvo F, Bate A, et al. The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine. Clinical Pharmacology & Therapeutics. 2026;119(2):318-321. doi:10.1002/cpt.70180
BibTeX
@article{Khouri2026,
author = {Khouri, Charles and Hlavaty, Alex and Fusaroli, Michele and Joshi, Nitin and Salvo, Francesco and Bate, Andrew and Pariente, Antoine and Raschi, Emanuel},
title = {The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
volume = {119},
number = {2},
pages = {318--321},
doi = {10.1002/cpt.70180}
}
EUVIMED